COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Medicure Inc. announces 2024 Q3 Financial Results conference call on November 26, 2024. Board member resigns. Company specializes in pharmaceuticals & healthcare products -
COMMUNIQUÉ DE PRESSE
Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113), a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor in Plaque Psoriasis
Protagonist announces positive Phase 3 ICONIC study results of icotrokinra, a first-in-class oral peptide for plaque psoriasis, achieving key endpoints and milestone payments under Johnson & Johnson collaboration -
